Lpath to Present at the Southern California Investor Conference

SAN DIEGO, CA--(Marketwire - August 14, 2009) - Lpath, Inc. (OTCBB: LPTN), the category
leader in therapeutic agents against bioactive lipids, will present at the
14th Annual Southern California Investor Conference being held on August
18, 2009 at the Island Hotel in Newport Beach, California.

The conference is hosted by California Equity Research and highlights the
abundance of growth companies located in the region, including
world-recognized life science, technology, media, and real estate/financial
companies.

Lpath President and CEO Scott R. Pancoast is scheduled to present on
Tuesday, August 18 at 9:30 a.m. Pacific time (12:30 p.m. Eastern time),
followed by a break-out session and one-on-one meetings. The presentation
will be available via webcast at
http://events.powerstream.net/002/00271/20090818SCIC-T3/.

For more information on the Southern California Investor Conference, please
visit the conference website at www.californiastocks.com or call the
conference desk at (858) 829-8688.

About Lpath

San Diego-based Lpath, Inc. is the category leader in lipidomics-based
therapeutics, an emerging field of medicine that targets bioactive
signaling lipids for treating a wide range of human disease. Lpath's
ImmuneY2T drug-discovery engine has the unique ability to generate
therapeutic antibodies that bind to and inhibit bioactive lipids that
contribute to disease. The company is currently advancing three drug
candidates, two of which -- ASONEPT for cancer and iSONEPT for AMD --
are in late-Phase 1 clinical trials, For ASONEP, Lpath has joined with
international drug giant Merck-Serono under a worldwide exclusive license
and development partnership. For more information, go to www.Lpath.com.